Amneal Pharmaceuticals, Inc.
AMRX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $18,132 | $35,610 | $24,618 | -$20,742 |
| Dep. & Amort. | $54,073 | $60,113 | $60,159 | $66,130 |
| Deferred Tax | -$23,355 | $0 | $0 | $0 |
| Stock-Based Comp. | $8,219 | $8,274 | $7,258 | $7,210 |
| Change in WC | -$50,738 | -$35,108 | -$106,380 | $21,855 |
| Other Non-Cash | $112,119 | $14,930 | $21,753 | $43,625 |
| Operating Cash Flow | $118,450 | $83,819 | $7,408 | $118,078 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$22,464 | -$27,402 | -$13,162 | -$22,464 |
| Net Acquisitions | $0 | $855 | $0 | $7,005 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | -$4,636 | -$600 |
| Investing Cash Flow | -$22,464 | -$26,547 | -$17,798 | -$16,059 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $67,214 | -$17,293 | -$17,528 | -$55,535 |
| Stock Issued | $653 | $685 | $69 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$8,424 | -$25,079 | -$21,707 | -$5,669 |
| Financing Cash Flow | $59,443 | -$41,687 | -$39,166 | -$61,204 |
| Forex Effect | -$639 | -$169 | -$470 | -$740 |
| Net Chg. in Cash | $154,790 | $15,416 | -$50,026 | $40,075 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $81,186 | $65,770 | $118,420 | $78,345 |
| End Cash | $235,976 | $81,186 | $68,394 | $118,420 |
| Free Cash Flow | $103,400 | $57,317 | -$10,914 | $95,014 |